UA15554A - METHOD FOR PREDICTING THE EFFECTIVENESS OF REFLECTOR THERAPY BY LAZORIC - Google Patents

METHOD FOR PREDICTING THE EFFECTIVENESS OF REFLECTOR THERAPY BY LAZORIC

Info

Publication number
UA15554A
UA15554A UA4729429A UA4729429A UA15554A UA 15554 A UA15554 A UA 15554A UA 4729429 A UA4729429 A UA 4729429A UA 4729429 A UA4729429 A UA 4729429A UA 15554 A UA15554 A UA 15554A
Authority
UA
Ukraine
Prior art keywords
effectiveness
predicting
lazoric
reflector
therapy
Prior art date
Application number
UA4729429A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Михайло Іванович Лазорик
Михаил Иванович Лазорик
Василь Васильович Марфинець
Василий Васильевич Марфинец
Original Assignee
Михайло Іванович Лазорик
Михаил Иванович Лазорик
Василь Васильович Марфинець
Василий Васильевич Марфинец
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Михайло Іванович Лазорик, Михаил Иванович Лазорик, Василь Васильович Марфинець, Василий Васильевич Марфинец filed Critical Михайло Іванович Лазорик
Priority to UA4729429A priority Critical patent/UA15554A/en
Publication of UA15554A publication Critical patent/UA15554A/en

Links

Landscapes

  • Electrotherapy Devices (AREA)

Abstract

Способ прогнозирования эффективности рефлексотерапии включает проведение исследований состояния организма. Определяются показатели фагоцитоза в мазке и в литре крови до начала лечения, до и после 3-4 сеансов и при снижении показателей более чем на 35% прогнозируется эффективность лечения.A method for predicting the effectiveness of reflexology includes conducting research on the state of the body. The indicators of phagocytosis in a smear and in a liter of blood are determined before the start of treatment, before and after 3-4 sessions, and with a decrease in indicators by more than 35%, the effectiveness of treatment is predicted.

UA4729429A 1989-08-14 1989-08-14 METHOD FOR PREDICTING THE EFFECTIVENESS OF REFLECTOR THERAPY BY LAZORIC UA15554A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA4729429A UA15554A (en) 1989-08-14 1989-08-14 METHOD FOR PREDICTING THE EFFECTIVENESS OF REFLECTOR THERAPY BY LAZORIC

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA4729429A UA15554A (en) 1989-08-14 1989-08-14 METHOD FOR PREDICTING THE EFFECTIVENESS OF REFLECTOR THERAPY BY LAZORIC

Publications (1)

Publication Number Publication Date
UA15554A true UA15554A (en) 1997-06-30

Family

ID=74355032

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4729429A UA15554A (en) 1989-08-14 1989-08-14 METHOD FOR PREDICTING THE EFFECTIVENESS OF REFLECTOR THERAPY BY LAZORIC

Country Status (1)

Country Link
UA (1) UA15554A (en)

Similar Documents

Publication Publication Date Title
AU6760987A (en) Method of treating alzheimer's disease
SE8803486L (en) DOSAGE FOR TREATMENT OF CARDIOVASCULAR DISEASES
IL76119A (en) Device for initiating reperfusion treatment when heart attack symptoms are present
ES2191068T3 (en) PROFILACTIC AND THERAPEUTIC TREATMENT OF SKIN SENSITIZATION AND IRRITATION.
MY106263A (en) Method for the treatment or prevention of intrinsically aged skin with retinoids
ATE128452T1 (en) S(+)-IBUPROFEN-L-AMINO ACID AND S(+)-IBUPROFEN-D-AMINO ACID AS ANALGESICS WITH GREATER PHARMACOLOGICAL POTENTIAL.
MX9303127A (en) METHOD FOR SELECTIVELY REDUCING THE CELL POPULATION OF LEUKOCYTES.
PT91953A (en) PROCESS FOR THE PREPARATION OF ANTIGEN SOLUTIONS CONTAINING ZINC HYDROXIDE OR IRON HYDROXIDE AS AN AUXILIARY AGENT
EP0413329A3 (en) 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases
UA15554A (en) METHOD FOR PREDICTING THE EFFECTIVENESS OF REFLECTOR THERAPY BY LAZORIC
GR3006674T3 (en)
DE3366663D1 (en) Method of treatment to induce ovulation in sheep or heifers
EA199900091A1 (en) THERAPEUTIC APPLICATION OF T-BAM (CD40L) -TECHNOLOGY FOR THE TREATMENT OF DISEASES WITH PARTICIPATION OF SMOOTH MUSCLE CELLS
DE69725897D1 (en) TREATMENT OF INTERFERENCE WITH INTERLEUKIN-9
CA2037709A1 (en) Use of zinc calcium hydroxide, lecithin and pao as an adjuvant for antigen solutions, and antigen solutions treated with an adjuvant of this type
GR850815B (en)
JPS51118547A (en) Facial treatment with intermittent direct current
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
JPS5212763A (en) Method of treating waste water
RU93031206A (en) METHOD OF TREATMENT OF GENITAL ENDOMETRIOSIS
UA6057A1 (en) Method for treating tuberculosis
SU1405143A1 (en) Method of treating acute diseases of cerebral circulation
EP0278715A3 (en) Use of human gamma interferon for treatment of basal cell carcinoma
RU93007819A (en) METHOD OF TREATING PATIENTS WITH CNS DISEASES AND DEVICE FOR IMPLEMENTING THE METHOD
MX9700626A (en) Method of treating opportunistic infections with azaspiranes.